New York State Teachers Retirement System Sells 58,421 Shares of Pediatrix Medical Group, Inc. $MD

New York State Teachers Retirement System trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 43.4% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 76,336 shares of the company’s stock after selling 58,421 shares during the period. New York State Teachers Retirement System’s holdings in Pediatrix Medical Group were worth $1,633,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in MD. Strs Ohio raised its stake in Pediatrix Medical Group by 6.5% in the 1st quarter. Strs Ohio now owns 41,100 shares of the company’s stock valued at $879,000 after acquiring an additional 2,500 shares during the period. Keybank National Association OH boosted its position in Pediatrix Medical Group by 2.0% during the first quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock worth $491,000 after purchasing an additional 458 shares during the period. Wasatch Advisors LP bought a new position in Pediatrix Medical Group during the first quarter worth $43,861,000. Louisiana State Employees Retirement System acquired a new position in shares of Pediatrix Medical Group in the first quarter valued at $798,000. Finally, Ritholtz Wealth Management increased its holdings in shares of Pediatrix Medical Group by 42.1% in the first quarter. Ritholtz Wealth Management now owns 143,668 shares of the company’s stock valued at $3,073,000 after purchasing an additional 42,553 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a research note on Friday, May 8th. UBS Group lifted their target price on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research note on Monday, April 20th. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Wednesday, June 24th. Finally, Truist Financial raised their price objective on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a research report on Monday, April 13th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Pediatrix Medical Group presently has a consensus rating of “Hold” and an average target price of $22.50.

Pediatrix Medical Group Price Performance

Shares of NYSE MD traded down $0.67 during mid-day trading on Friday, reaching $26.25. The company had a trading volume of 559,631 shares, compared to its average volume of 769,692. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.33 and a current ratio of 1.33. Pediatrix Medical Group, Inc. has a one year low of $11.84 and a one year high of $27.94. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of 12.74 and a beta of 0.66. The business’s 50-day simple moving average is $23.58 and its 200 day simple moving average is $22.05.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. The business had revenue of $476.20 million during the quarter, compared to analysts’ expectations of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. Pediatrix Medical Group’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.33 earnings per share. On average, research analysts predict that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.80% of the stock is currently owned by corporate insiders.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.